Pepticom set to develop AI models enabling peptide-based drug discovery
Pepticom’s technology aims to ‘vastly reduce’ risk of failure in peptide drug candidates’ discovery and development, by utilizing artificial intelligence models.
Archives for October 24, 2019
Sanofi and Dr Reddy’s join the ranitidine recall
Both companies issue a voluntary recall of their ranitidine-based products due to the ongoing investigation into cancer-causing contamination.
Foamix enters commercial supply agreement for topical foam antibiotic
Foamix signs deal with ASM for the commercial manufacture and supply of recently approved Amzeeq and its lead candidate, FMX103.
GE Healthcare sets up UK biotech R&D lab
GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.
SignalPath raises $18m ahead of trial management platform expansion
SignalPath announced the closing of its Series B funding round to support the expansion of its software platform, which facilitates clinical trials management.
How personalized medicines are disrupting the supply chain
Paid for and content provided by Marken
Sponsors for a Phase 2 clinical trial needed an expensive, time-sensitive therapy transported to investigator sites at -80º C. Further, when reaching out to cryogenic shipper rental companies, the sponsor found they often transport regionally and do not...